WILLIAM ROWALT: Open Payments
NPI 1356961494 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 42 payments from 14 companies in 2025. Trend: 2023 $2,308 · 2024 $2,152 · 2025 $1,670
Food & beverage: $1,670
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $317 |
| Abbott Laboratories | 7 | $287 |
| Amgen Inc. | 5 | $207 |
| BridgeBio Pharma, Inc. | 2 | $165 |
| Novo Nordisk Inc | 2 | $150 |
| Alnylam Pharmaceuticals Inc. | 3 | $125 |
| Shockwave Medical, Inc | 1 | $104 |
| PFIZER INC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
Products named: CARDIOMEMS, Attruby, Ozempic, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, AMVUTTRA, ONPATTRO, ELIQUIS, REPATHA.
Industry payments across LA — which companies pay providers there.
